Reply to "Comment on direct bilirubin as predictor of severity and mortality in idiopathic pulmonary arterial hypertension".
作者信息
Xu Xi-Qi, Zhang Hong-Da, Jing Zhi-Cheng
机构信息
State Key Lab of Cardiovascular Disease, FuWai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
State Key Lab of Cardiovascular Disease, FuWai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
出版信息
Int J Cardiol. 2017 Jul 15;239:36. doi: 10.1016/j.ijcard.2017.05.034.
PMID:28560981
Abstract
摘要
相似文献
1
Reply to "Comment on direct bilirubin as predictor of severity and mortality in idiopathic pulmonary arterial hypertension".对“关于直接胆红素作为特发性肺动脉高压严重程度和死亡率预测指标的评论”的回复
Int J Cardiol. 2017 Jul 15;239:36. doi: 10.1016/j.ijcard.2017.05.034.
2
Comment on direct bilirubin as predictor of severity and mortality in idiopathic pulmonary arterial hypertension.关于直接胆红素作为特发性肺动脉高压严重程度和死亡率预测指标的评论
Int J Cardiol. 2017 Jul 15;239:35. doi: 10.1016/j.ijcard.2017.04.068.
3
Pulmonary arterial capacitance index is a strong predictor for adverse outcome in children with idiopathic and heritable pulmonary arterial hypertension: methodological issues to avoid misinterpretation.肺动脉容量指数是特发性和遗传性肺动脉高压患儿不良预后的有力预测指标：避免误解的方法学问题。
J Pediatr. 2017 May;184:239-240. doi: 10.1016/j.jpeds.2017.01.030.
4
Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension.直接胆红素：特发性肺动脉高压不良预后的一个新危险因素。
Int J Cardiol. 2017 Feb 1;228:895-899. doi: 10.1016/j.ijcard.2016.11.036. Epub 2016 Nov 7.
5
[Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].小儿特发性肺动脉高压的预后及相关危险因素分析
Zhonghua Er Ke Za Zhi. 2018 Jan 2;56(1):23-28. doi: 10.3760/cma.j.issn.0578-1310.2018.01.007.
6
A Step Closer to Mechanism and Additional Targeted Therapies for Pulmonary Arterial Hypertension: Links between Red Blood Cell Lysis and Vascular Dysfunction in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2018 Sep;59(3):279-280. doi: 10.1165/rcmb.2018-0136ED.
7
VEGF165b elevation in pulmonary arterial hypertension patients, causative or adaptive? -Reply.肺动脉高压患者中VEGF165b升高：是病因还是适应性反应？-回复
Int J Cardiol. 2018 Apr 1;256:32. doi: 10.1016/j.ijcard.2017.11.042.
8
Phenotypes of idiopathic pulmonary arterial hypertension - Authors' reply.特发性肺动脉高压的表型——作者回复
Lancet Respir Med. 2022 Oct;10(10):e90-e91. doi: 10.1016/S2213-2600(22)00273-9.
9
Age, risk and outcomes in idiopathic pulmonary arterial hypertension.特发性肺动脉高压的年龄、风险与预后
Eur Respir J. 2018 May 3;51(5). doi: 10.1183/13993003.00629-2018. Print 2018 May.
10
Epidemiology of pulmonary arterial hypertension.肺动脉高压的流行病学。
Clin Chest Med. 2013 Dec;34(4):619-37. doi: 10.1016/j.ccm.2013.08.010. Epub 2013 Oct 18.
Zotero 插件